Tuesday, October 19, 2021
Mitochondrial Health

Public Meeting on Patient Focused Drug Development for Inborn Errors of Metabolism Part 2

On June 10, 2014, FDA hosted a public meeting on Patient-Focused Drug Development for Inborn Errors of Metabolism. FDA was interested in obtaining patient perspectives on the impact of Inborn Errors of Metabolism on daily life and patient views on treatment approaches. For more information, visit https://go.usa.gov/x69cX.


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *